Published in

Elsevier, Diagnostic Microbiology and Infectious Disease, 4(75), p. 440-442

DOI: 10.1016/j.diagmicrobio.2013.01.014

Links

Tools

Export citation

Search in Google Scholar

Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV test for management of CMV disease in transplant recipients

Journal article published in 2013 by Bobbi S. Pritt ORCID, Jeffrey J. Germer, Eric Gomez-Urena, Callie J. Bishop, Jayawant N. Mandrekar, Cole L. Irish, Joseph D. C. Yao
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Testing of clinical plasma specimens by the COBAS AmpliPrep/COBAS TaqMan CMV Test (CAP/CTM CMV), COBAS AMPLICOR CMV MONITOR Test (CAM CMV), and a laboratory-developed assay using analyte-specific reagents (LC CMV) demonstrated substantial result bias for CAP/CTM CMV versus CAM CMV (r = 0.436) and CAP/CTM CMV versus LC CMV (r = 0.773).